Sigilon Therapeutics Company
Sigilon is a biotech company which specializes in creating immune privileged products for unmet clinical needs.
Founded Date:
2015
Total Funding:
263200000
Investor Type:
IPO
Employee Number:
51-100
Last Funding Type:
Post-IPO Equity
Investors Number:
5
Last Funding Date:
2020
Industry:
Biotechnology
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
$10M to $50M